Today, on 30 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2014 to “Nasdaq OMX Riga”. Non-audited financial...
Today, on 30 April, JSC Grindeks has submitted the audited consolidated financial statements for 2013 to “Nasdaq OMX Riga”. Audited financial results show that the...
From 22 to 24 October, 2013, Grindeks participates in the leading pharmaceutical exhibition “CPhI Worldwide 2013” in Frankfurt, Germany. During the exhibition Grindeks will meet...
The management system of JSC Grindeks has received the Russian ГОСТ (GOST) certificate of quality ISO 9001-2011. This was reported by representatives of the company....
JSC Grindeks is pleased to announce the successful passing of the U.S. Food and Drug Administration inspection. The issued certification paves the way for Grindeks...
JSC Grindeks was named among 25 most influental Latvian exporting enterprises. The award ceremony was organised by the society for Latvian exporters’ support, “The Red...
JSC Grindeks informs that according to the decision taken at the shareholder meeting, the company will keep the yearly profit undivided and will not distribute...
